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 33 
The metalation reactions between [Pt2(4-MeC6H4)4(μ-SEt2)2] and 2-X,6-FC6H3CHvNCH2CH2NMe2 34 
(X = Br, Cl) have been studied. In all cases, seven-membered platinacycles are formed in a process that 35 
involves an initial reductive elimination from cyclometallated PtIV intermediate compounds, [PtX(4-36 
CH3C6H4)2(ArCHvNCH2CH2NMe2)] (X = Br, Cl), followed by isomerization of the resulting PtII 37 
complexes and a final cyclometallation step. For the process with X = Br, the final seven-membered 38 
platinacycle and two intermediates, isolated under the conditions implemented from parallel kinetic 39 
studies, have been characterized by XRD. Contrary to previous results for the parent non-fluorinated 40 
imine 2-BrC6H4CHvNCH2CH2NMe2 the presence of a fluoro substituent prevents the formation of the 41 
more stable five-membered platinacycle. Temperature and pressure dependent kinetico-mechanistic and 42 
DFT studies indicate that the final cyclometallation step is strongly influenced by the nature of the 43 
spectator halido ligand, the overall reaction being much faster for X = Cl. The same DFT study 44 
conducted on the previously studied systems with imine 2-BrC6H4CHvNCH2CH2NMe2 indicates that, 45 
when possible, fivemembered platinacycles are kinetically preferred for X = Br, while the presence of Cl 46 
as a spectator halido ligand leads to a preferential faster formation of seven-membered analogues. 47 
 48 
  49 
INTRODUCTION 50 
 51 
Reductive elimination reactions have attracted a great deal of interest since they may lead to the 52 
formation of new bonds, in either stoichiometric or catalytic transformations. In particular, Pt(IV) 53 
compounds are considered adequate models to study reductive elimination processes from d6 octahedral 54 
complexes. Recent findings based on reductive elimination from platinum(IV) complexes include the 55 
formation of C–C and C–halide bonds1 and a catalytic process for conversion of a C–F bond into a C–C 56 
bond.2 In particular, cyclometallated platinum(IV) compounds [PtXR2(Ar′CHNCH2CH2NMe2)] or 57 
[PtXR2 (Ar′CHNCH2Ar′)L] containing respectively a tridentate [C,N,N′] ligand or a bidentate [C,N] 58 
and a neutral monodentate L ligand can be easily obtained from the reactions of platinum precursors 59 
containing “PtR2” moieties and potentially tridentate or bidentate imine ligands, 60 
Ar′CHNCH2CH2NMe2 or Ar′CHNCH2Ar′. In recent years, we have been involved in studies related to 61 
the formation of platinum(II) cyclometallated compounds generated from the mentioned platinum(IV) 62 
cyclometallated compounds with tridentate [C,N,N′] amino–imine ligands, or bidentate [C,N] imine 63 
ligands, and a neutral monodentate ligand L.3–12 The interest in these reactions arises from the fact that 64 
along the process new C–C bonds are formed via an initial reductive elimination to give a 65 
noncyclometallated platinum(II) compound that, in the second step, evolves towards a cycloplatinated 66 
compound. Although a common sequence operates, this process is highly versatile since both the nature 67 
of the formed C–C bond and the structure of the final cyclometallated platinum(II) compound can be 68 
tuned by a judicious choice of both the platinum precursor “PtR2” and the imine ligand, 69 
Ar′CHNCH2CH2NMe2 or Ar′CHNCH2Ar′, used in the formation of the cyclometallated platinum(IV) 70 
compound. For instance, the reaction of [Pt2Me4(μ-SMe2)2] with imine ligands Ar′CHNCH2Ar′ leads 71 
to a cyclometallated platinum(IV) compound from which Caryl–Calkyl bonds are formed and the 72 
subsequent metalation can lead to either five or six-membered metallacycles corresponding to C–H 73 
activation at the aryl group of the imine, or at the methyl ligand of the platinum precursor, respectively 74 
(Scheme 1).3,5 75 
For diarylplatinum precursors, the corresponding platinum(IV) compounds lead to the formation of 76 
Caryl–Caryl bonds from which either seven-membered platinacycles containing the new biaryl fragment 77 
or five-membered analogues, in which the newly formed C–C bond is outside the metallacycle, can be 78 
obtained.4,6,7,9–12 For the former, C–H bond activation takes place at the aryl ligand of the precursor, 79 
while for the latter this process takes place at the aryl ring of the imine. A clear example (Scheme 2) is 80 
obtained when cis-[Pt(C6F5)2(SEt2)2] is used, since, in this case, the ortho-fluorine substituents 81 
preclude the formation of seven-membered platinacycles, due to the low reactivity of C–F bonds, and 82 
therefore the reaction is directed towards the formation of five-membered analogues.8 83 
A more striking result, shown in Scheme 3, was obtained in the reaction of [Pt2(4-MeC6H4)4(μ-SEt2)2] 84 
with imines 2-XC6H4CHvNCH2CH2NMe2 (X = Br or Cl) since, in this case, the nature of the halide is 85 
determinant: a five-membered platinacycle is obtained for X = Br, while a seven-membered platinacycle 86 
is produced for X = Cl. This system has been thoroughly studied from a kinetico-mechanistic point of 87 
view and although formation of a seven-membered platinacycle for X = Br was found plausible under 88 
harsher conditions, the compound could not be obtained in a pure form.4 89 
Since seven-membered platinacycles are a novel class of compounds with potential interest associated 90 
with their cytotoxic properties,13,14 in addition to the intrinsic interest based on the formation of biaryl 91 
linkages, we decided to explore novel strategies in order to analyse whether it would be possible to 92 
obtain such compounds even when X = Br. In this work, the reactions of [Pt2(4-MeC6H4)4(μ-SEt2)2] 93 
with imines 2-X,6-FC6H3CHvNCH2CH2NMe2 (X = Br or Cl) have been studied with the idea that the 94 
fluoro substituent at the ortho position in the aryl ring of the imine ligand should prevent the C–H bond 95 
activation at the imine and thus, in both cases, the reaction would be driven towards the formation of 96 
seven-membered platinacycles rather than five-membered analogues. It should be noted that five-97 
membered metallacycles are more stable than other ring products and generally cyclometallation 98 
reactions take place with high regioselectivity to produce fivemembered rings.15–17 Kinetico-99 
mechanistic and DFT studies of these types of systems should allow studying the effect of the nature of 100 
the halide (Br versus Cl) in the formation of sevenmembered platinacycles. 101 
  102 
RESULTS AND DISCUSSION 103 
 104 
Preparation and characterisation of compounds 105 
Initial platinum(IV) compounds [PtX(4-MeC6H4)2(2-FC6H3CHv NCH2CH2NMe2)] (5-IV-X,F, X = 106 
Br and Cl; Scheme 4) were prepared in high yields, following previously established procedures, from 107 
[Pt2(4-MeC6H4)4(μ-SEt2)2] and imines 2-X,6- FC6H3CHvNCH2CH2NMe2 (X = Br and Cl).18 For X 108 
= Br the reaction was faster and was complete within 24 hours in toluene solution at room temperature, 109 
while for X = Cl the reaction requires 48 hours under the same conditions. As expected from the lower 110 
reactivity of C–F bonds, activation of this bond was not observed in either reaction. Using shorter 111 
reaction times, isolation and characterisation of the coordination compound [Pt(4-MeC6H4)2(2-F,6-112 
ClC6H3CHvNCH2CH2NMe2)], formed prior to the intramolecular C–Cl bond activation has also been 113 
achieved; isolation of the corresponding bromo analogue has not been possible. In this case the 114 
intramolecular C–Br bond activation occurred readily after coordination of the imine ligand to platinum. 115 
All the isolated compounds were characterized by 1H and 19F NMR spectra, which were consistent 116 
with the expected structures as well as from the data available for analogous compounds.4,9 As 117 
expected, the J(Himine–Pt) values observed for the platinum(IV) compounds (45.6 and 46.0 Hz) are 118 
lower than those observed for the platinum(II) compound [Pt(4-MeC6H4)2(2-F,6-119 
ClC6H3CHvNCH2CH2NMe2)] (50.8 Hz). For the latter, the J(Himine–Pt) value is consistent with both 120 
an E conformation of the imine moiety and the presence of an aryl ligand trans to this group.4 A set of 121 
signals of very low intensity that could not be fully assigned indicated also the presence of a Z isomer in 122 
the sample in small amounts (<5%). 123 
When a toluene solution of compound 5-IV-Br,F was refluxed for 24 hours, the targeted seven-124 
membered platinacycle [PtBr{(4-MeC6H3)(2-FC6H3)CHNCH2CH2NMe2}] (7-II-Br,F) was obtained. 125 
This compound could also be obtained in a onepot process from [Pt2(4-MeC6H4)4(μ-SEt2)2] and the 126 
corresponding 2-Br,6-FC6H3CHvNCH2CH2NMe2 imine under the same conditions. These results 127 
indicate that the presence of an inert C–F bond in the imine ligand is an efficient strategy to drive the 128 
reaction towards the formation of seven-membered platinacycles. Formation of the analogue chlorido 129 
compound [PtCl{(4-MeC6H3)(2-FC6H3)CHNCH2CH2NMe2}] (7-II-Cl,F) took place much more 130 
readily, since refluxing in toluene for 6 hours either a solution of the platinum(IV) compound 5-IV-Cl,F 131 
or a mixture of [Pt2(4-MeC6H4)4(μ-SEt2)2] and imine 2-Cl,6-FC6H3CHvNCH2CH2NMe2, produced 132 
the desired compound. NMR data are in good agreement with those reported for analogous compounds 133 
with chlorido ligands.9,13 The high value obtained for 3J(Himine–Pt) (150.4 Hz) is consistent with both 134 
the E conformation of the imine and the presence of an halide trans to the imino group.4 135 
Suitable crystals of compound 7-II-Br,F were grown from dichloromethane–methanol at room 136 
temperature, and XRD analysis was possible from the crystals obtained, showing that the structure is 137 
composed of discrete molecules separated by van der Waals distances (Fig. 1a); selected bond data are 138 
listed in Table 1. The complex shows a square-planar coordination of the platinum(II) with a terdentate 139 
[C,N,N′] unit and a bromo ligand. The metallacycle consists of a non-planar seven-membered system in 140 
which the biaryl fragment and the imine functionality are included. Bond lengths and angles are well 141 
within the range of values obtained for analogous compounds,9,13 the Pt–Br bond length being slightly 142 
longer than the reported Pt–Cl lengths for compounds of the same type. Most bond angles at platinum 143 
are close to the ideal value of 90°, and the smallest angle corresponds to the chelate N–Pt–N bite angle. 144 
To confirm whether the formation of seven-membered platinacycles from the corresponding 145 
platinum(IV) cyclometallated compounds follows a common sequence, regardless of the presence of a 146 
chlorido or a bromido ligand, time-resolved experiments were conducted. A xylene solution of the 147 
complexes was monitored at different temperatures and times to ascertain the best set of conditions 148 
where the intermediates were present in representative amounts. Proton NMR studies revealed that after 149 
stirring a solution of 5-IV-Br,F for 90 minutes at 70 °C, 90% of the sample had progressed to the 150 
dangling biphenyl intermediate form II-Br,F (Scheme 4). From the reaction mixture, suitable crystals of 151 
the intermediate could be obtained in its E form, allowing for full XRD characterization as its CH2Cl2 152 
solvato species. The relatively low value of 3J(Himine–Pt) (35.6 Hz) is in the range expected for 153 
compounds with an aryl ligand trans to the imino group and an E conformation of the imine.4 The 154 
molecular structure is also shown in Fig. 1b and selected molecular dimensions are listed in Table 1. The 155 
square-planar coordination of the platinum(II) is achieved with a bidentate [N,N′] ligand, a bromido, 156 
trans to the dimethylamino moiety, and a para-tolyl ligand. The bond lengths and angles are well within 157 
the range of values obtained for analogous compounds.4 Again, most of the bond angles at platinum are 158 
close to the ideal value of 90°, and the smallest angle corresponds to the chelate N–Pt–N bite angle. The 159 
crystal structure of this compound confirms that a biphenyl fragment involving a former para-tolyl 160 
ligand and the aryl ring of the initial ligand is formed from 5-IV-Br,F in a reductive elimination process. 161 
As already reported, the compounds generated on reductive elimination on platinum(IV) compounds of 162 
the type 5-IV-X,Y may adopt four distinct isomeric forms (see Scheme 5); the aryl ring being trans to 163 
the amine or the imine moieties and with an E or Z imine conformation.4 By monitoring changes in the 164 
1H NMR spectra of II-Br,F, under the conditions suggested by the kinetic experiments detailed in the 165 
next section, compound II′-Br,F, as a mixture of E and Z isomers in a proportion E : Z = 2 : 1, was 166 
obtained. As previously reported,4 the values of J(Himine–Pt), which in this case are 152 Hz and 84 Hz 167 
for the E and Z isomers, respectively, indicate the presence of an halide ligand trans to the imine. From 168 
this mixture, XRD quality crystals were obtained and analysed; the molecular structure is shown in Fig. 169 
1c and selected molecular dimensions are listed in Table 1. This compound differs from the previously 170 
described intermediate in that the bromido ligand is now trans to the imino fragment, and the latter 171 
displays a Z arrangement. A careful examination of this Z isomeric form of the species results in clear 172 
evidence that this form cannot produce the final seven membered platinacycles for orientation reasons. 173 
A similar treatment carried out on compound II-Cl,F produced rather complex 1H NMR spectra which 174 
consist of mixtures of up to four possible isomers of the species plus the initial and final reaction 175 
compounds (i.e. 5-IV-Cl,F and 7-II-Cl, F). From these complex mixtures, already anticipated from the 176 
data collected in the next section, it was not possible to isolate any of the relevant species. 177 
 178 
Kinetico-mechanistic studies on the formation of sevenmembered 7-II-Br,F and 7-II-Cl,F 179 
metallacycles 180 
The rather complex nature of both the possible reaction intermediates and the nature of the final 181 
cyclometallated complexes formed in the reactions is generalised in Scheme 5. This general scheme is 182 
clear both from some previous results already published,4,19 and those indicated in the previous section. 183 
Given the fact that time-resolved monitoring of the processes has been found to be a perfect handle to 184 
gain a better insight into the reaction mechanism, the UV-Vis monitoring of the transformation of 185 
complexes 5-IV-X,F has been conducted from a kinetic perspective. 186 
For complex 5-IV-Br,F the spectral changes observed on monitoring 5 × 10−4 M xylene solutions at 187 
varying temperatures indicate the operation of a two-step process in the 2–24 hour range at 90 and 60 °C 188 
respectively. By using the standard software indicated in the Experimental section, these changes could 189 
be easily fitted to a consecutive set of two single exponentials. From the time scale, as well as from 190 
parallel NMR monitoring, and the preparative procedures indicated before these processes correspond to 191 
the reductive elimination from 5-IV-Br,F to II-Br,F followed by isomerisation to II′-Br,F. The follow up 192 
final reaction to produce 7-II-Br,F could not be monitored due to the high temperature needed as well as 193 
for its time scale. Table 2 collects the relevant kinetic and activation data derived from the plots shown 194 
in Fig. 2a for the processes monitored, together with other relevant data for similar processes. The data 195 
indicate that the mechanism operating for the full process perfectly parallels that found for the reactivity 196 
of the similar 5-IV-Br,H, although in the present case the formation of the final five-membered 197 
platinacycle is hindered by the presence of the fluoro substituent at the remaining ortho position of the 198 
initial imine ligand. Formation of the seven membered 7-II-Br,F species is much slower, and it only 199 
occurs due to the blockage of the position leading to the 5-II-Br,H complex. From the thermal and 200 
pressure activation parameters it is clear that the reductive elimination reaction, i.e. 5-IV-Br,F → II-201 
Br,F, requires a rather large activation enthalpy with practically no changes in entropy, which indicates a 202 
transition state with a dominant breaking of the two Pt–C bonds, but keeping them organised by an 203 
incipient C–C bond making. This is the behaviour expected for this type of general reductive elimination 204 
reactions. As for the volume of activation (Fig. 2b), it is in line with a small compression, precisely due 205 
to the new C–C bond being formed. As for the II-Br, F ⇄ II′-Br,F isomerisation reaction monitored, the 206 
activation parameters agree perfectly well with those obtained for the already studied II-Br,H ⇄ II′-Br,H 207 
process. The values of the entropy and volume of activation are very negative, in line with a rather 208 
ordered and compressed transition state. Probably the highest point in the energy of the process 209 
corresponds to the formation of the new Pt–NMe2 bond from a triangular-planar previously dissociated 210 
intermediate arrangement. Consequently, the value of the activation enthalpy for the process has to be 211 
rather low, as observed, given the non-limiting dissociation of the Pt–N bond. 212 
The parallel study carried out on the 5-IV-Cl,F → 7-II-Cl,F process proved to be much more complex to 213 
be monitored. As indicated in the previous section, 1H NMR monitoring of the process according to the 214 
time-resolved changes obtained by UV-Vis indicated that the presence of a mixture of the four isomeric 215 
forms plus the final species indicated in Scheme 5 is prevalent under all the reaction conditions. The 216 
slowest process of the three step sequence observed was associated with the II-Cl,F ⇄ II′-Cl,F reaction, 217 
as an increase of concentration of the II′-Cl,F form is observed at this time-scale by 1H NMR 218 
monitoring; kinetics could be monitored with low methodological errors by UV-Vis. Contrarily, the 219 
initial fast reductive elimination reaction proved to be the most complicated to determine kinetically due 220 
to the low solubility of 5-IV-Cl,F in xylene at temperatures lower than 50 °C and the readiness of the 221 
process (see Table 2). Given the fact that the outcome of the full process under the conditions studied is 222 
the final 7-II-Cl,F the remaining step observed was associated with the oxidative II′-Cl,F → 7-II,Cl,F 223 
reaction. The kinetic and thermal activation parameters determined for all these sets of reactions are also 224 
indicated in Table 2 along with the results for the other relevant systems. Clearly the data agree very 225 
well with those observed for the similar systems studied. It is thus clear that the relative ease of 226 
formation of the final 7-II-X,F sevenmembered platinacycles is dictated by the presence of a X = Br or 227 
X = Cl donor in the II′-X,F → 7-II,X,F reaction, while the II-X, Y ⇄ II′-X,Y isomerisation process does 228 
not distinguish between the different X and Y donors on the platinum centre. 229 
 230 
DFT calculations 231 
In view of the data collected in Table 2, DFT calculations have been conducted at 139 °C (xylene 232 
boiling point) in order to establish which of the reaction steps indicated in Scheme 5 could be 233 
responsible for the prevalence of the species 7-II-Cl,H and 7-II-Cl,Cl, while only the 5-II-Br,H complex 234 
is observed,4 instead of the expected 7-II-Br,H. The results should be then extrapolated to the present 235 
situation, 7-II-Cl,F and 7-II-Br,F, where complexes of type 5-II-Br,F are not possible due to the 236 
blocking design effect of the ligand used. Initial DFT calculations indicate that all E forms of II-X,H and 237 
II′-X,H are lower in energy than their corresponding Z analogues (Table 3). Since the reaction leading to 238 
the final products proceeds via the E isomeric form of the II′-X,H intermediates (vide infra), Z isomers 239 
can be considered irrelevant to the reaction course. Furthermore, as indicated in the previous sections, 240 
the distal C–H bond is too far away from the platinum(II) centre to be relevant for the oxidative addition 241 
process. From the data in Table 3 it is clear that the energies of the II′-X,H intermediates are in all cases 242 
lower than those of the II-X,H species, indicating that an isomerization process should be expected, as 243 
observed experimentally. The isomerization transition state (TS_Isom), involving a three coordinated 244 
platinum species with a dangling NMe2 group (Fig. S1†), was also calculated and found to be around 245 
140 kJ mol−1 above II-X,H (see Table 3). The geometry of the calculated TS_Isom involves a rather 246 
late C–Pt–Nimine angle (180° (II-X,H) → 130° (TS_Isom) → 90° (II′-X, H)), in good agreement with 247 
the kinetic activation data obtained experimentally. 248 
Once the most stable II′-X,H intermediate is formed, two possible selective parallel pathways, leading to 249 
the characterised metallacycles, are possible. The first one (Scheme 6, top) involves the oxidative 250 
addition of the C–HA bond at the platinum followed by the reductive elimination of toluene producing 251 
the five-membered platinacycle (5-II-X,H). The equivalent seven-membered platinacycle (7-II-X,H) 252 
would be obtained in a similar fashion whenever the C–HB bond is activated at the metal (Scheme 6, 253 
bottom). Given the fact that five-membered platinacycles are more stable than their seven-membered 254 
counterparts (the calculated free energy difference being 31.8 (X = Br) and 33.4 (X = Cl) kJ mol−1, as 255 
expected from simple standard considerations)17,19,20 the obtention of the larger seven-membered 256 
platinacycle from the II′-Cl,H intermediate has to be due to kinetic preferences. 257 
A close look at the energy barriers calculated for the formation of 5-II-Cl,H and 7-II-Cl,H reveals that 258 
the seven-mem- bered product is, indeed, the favoured one. While the barriers obtained for the formation 259 
of the 5-II-Cl,H five-membered platinacycle are 128.4 (oxidative addition, TS_CHA) and 155.6 260 
(reductive elimination, TS_RE1) kJ mol−1, the formation of the seven-membered platinacycle 261 
compound, 7-II-Cl,H, produces 149.8 (TS_CHB) and 149.1 (TS_RE2) kJ mol−1 equivalent barriers, 262 
which imply the lower overall energy requirements. For the bromido analogues the outcome of DFT 263 
calculations produces the opposite trend, with the barriers favouring the formation of the five-membered 264 
product (see Scheme 6). In this case the energy requirements for oxidative addition (TS_CHA) and 265 
reductive elimination (TS_RE1) for the smaller five-membered platinacycles are 119.6 and 141.5 kJ 266 
mol−1 respectively, slightly lower than those found for the seven-membered product: 146.4 (TS_CHB) 267 
and 145.1 (TS_RE2) kJ mol−1. It may be argued that the final products could also be obtained from the 268 
II-X,H isomeric form, but higher barriers were obtained for these pathways both for X = Br and X = Cl. 269 
Other possible pathways such as those involving the C–H activation on the tetracoordinated square 270 
planar platinum centre of II′-X,H, or σ-CAM processes21 leading to the final products, were also 271 
computed and found to be noncompetitive with the mechanism proposed here. 272 
The results collected in Scheme 6, which are clearly in line with the experimental observations, have 273 
been used to build a qualitative kinetic simulation model of product formation over time. For this 274 
purpose, the relative free energy differences have been transformed into rate constants by using the 275 
Eyring–Polanyi equation (i.e. k = (kbT/h) exp(−ΔG‡/RT)), and the product evolution over time, from 276 
II′-X,H, has been calculated (Fig. 3). As may be observed, at 139 °C the product distribution trend 277 
matches the experimental observations: 5-II-Br,H is produced with preference to 7-II-Br,H from II′-278 
Br,H, whereas the inverse (7-II-Cl,H preferably to 5-II-Cl,H) is observed for II′-Cl, H. Although the 279 
time scale in Fig. 3 reasonably matches the values for X = Br (50% conversion after 24 h), for X = Cl 280 
there is more than an order of magnitude difference. Nevertheless, in this high energy range, this 281 
difference is easily overcome when the methodological errors involved in the DFT calculation (4–16 kJ 282 
mol−1) are taken into account. 283 
The validity of the mechanism in Scheme 6 has also been confirmed by its use in the formation of the 284 
fluorinated compounds 7-II-Br,F and 7-II-Cl,F characterised in the present work, for which the 285 
formation of the five-membered platinacycle 5-II-X,F is not possible. The calculated energy 286 
requirements (Table S2†), although very similar, are slightly lower for the X = Cl system, indicating that 287 
the formation of 7-II-Cl,F should be definitively faster. In fact, the qualitative kinetic model indicates 288 
that 7-II-Cl,F is obtained around four times faster than 7-II-Br,F, practically the same difference as 289 




In this work, the mechanism of formation of seven-membered platinacycles, in preference to the more 294 
thermodynamically stable five-membered analogues, has been disclosed through combined kinetico-295 
mechanistic and computational studies. Seven-membered platinacycles are formed as the kinetically 296 
favoured products in a process which involves the reductive elimination from cyclometallated 297 
platinum(IV) compounds [PtX(4-CH3C6H4)2(ArCHvNCH2CH2NMe2)] (X = Br, Cl), followed by 298 
isomerization of the resulting platinum(II) compounds plus a final cyclometallation step. The results 299 
indicated that the nature of the spectator halido ligand X (X = Br or Cl) is determinant in the 300 
platinacycle size of reaction products. The presence of a bromido ligand slows down the formation of 301 
seven-membered platinacycles in such a way that the formation of the five-membered analogue becomes 302 
competitive unless the required metalation site is blocked with a fluoro substituent. Both kinetico-303 
mechanistic and computational studies indicate that, contrary to previous suggestions, the isomerization 304 
step is not significantly affected by the nature of the halido ligand. On the contrary, all data are 305 
consistent with the fact that the final cyclometallation step is only dependent on the nature of the 306 
spectator halido ligand and this step is responsible for the nature of the final products. Therefore, five-307 
membered platinacycles are preferred for Br, while the presence of a Cl leads to the formation of 308 
sevenmembered analogues. 309 
  310 
EXPERIMENTAL 311 
 312 
General procedures 313 
Microanalyses were performed at the Centres Científics I Tecnològics (Universitat de Barcelona). 314 
Electrospray mass spectra were performed at the Servei d’Espectrometria de Masses (Universitat de 315 
Barcelona) using a LC/MSD-TOF spectrometer usingH2O–CH3CN 1 : 1 to introduce the sample. NMR 316 
spectra were performed at the Unitat de RMN d′Alt Camp de la Universitat de Barcelona using a 317 
Mercury-400 spectrometer (1H, 400 MHz; 19F, 376.5 MHz) and referenced to SiMe4 (1H) or CFCl3 318 
(19F). The δ values are given in ppm and J values in Hz. Abbreviations used: s = singlet; d = doublet; t 319 
= triplet; q = quartet; m = multiplet. 320 
 321 
Preparation of complexes 322 
The compounds [Pt2(4-MeC6H4)4(μ-SEt2)2]22 and 2-Cl,6-FC6H3CHvNCH2CH2NMe2 23 were 323 
prepared as reported elsewhere. Compound 7-II-Cl,F has been previously reported.13 324 
2-Br,6-FC6H3CHvNCH2CH2NMe2 (Chart 1). To a solution of N,N-dimethylethylenediamine (0.22 325 
g, 2.4 × 10−3 mol) in toluene was added 2-bromo,6-fluorobenzaldehyde (0.50 g, 2.7 × 10−3 mol), and 326 
the solution was allowed to stir at room temperature for 70 minutes. The mixture was dried over 327 
Na2SO4, the solution was filtered, and the solvent was removed under vacuum to give the product. 328 
Yield: 0.65 g (97%). 1H NMR (CDCl3, 298 K), δ: 8.47 [s, 1H, H1]; 7.40 [dd, 1H, 3J(H2–H4) = 8.0, 329 
H2]; 7.20 [td, 1H, 3J(H3–H4) = 3J(H3–F) = 8.0, 4J(H3–H2) = 5.6, H3]; 7.08 [td, 1H, 3J(H4–H2,3) = 330 
8.0, H4]; 3.82 [t, 2H, 3J(H5–H6) = 6.8, H5]; 2.69 [t, 2H, 3J(H6–H5) = 7.0, H6]; 2.32 [s, 6H, H7]. 19F 331 
NMR (CDCl3, 298 K), δ: −111.70 [dd, 3J (F–H) = 10.4, 4J (F–H) = 6.0]. ESI-MS, m/z: 273.04 [M + 332 
H]+. 333 
[PtBr(4-MeC6H4)2{2-FC6H3CHvNCH2CH2NMe2}] (5-IV-Br,F, Chart 2). A mixture of 334 
compounds [Pt2(4-MeC6H4)4(μ-SEt2)2] (100 mg, 1.06 × 10−4 mol) and 2-Br,6-FC6H3CHv 335 
NCH2CH2NMe2 (60 mg, 2.19 × 10−4 mol) was dissolved in 20 ml of toluene and was left for stirring at 336 
room temperature for 24 hours. The solvent was removed under vacuum to yield an oily residue. The oil 337 
was treated with diethyl ether and upon removal of ether under vacuum a yellow powder was obtained. 338 
Yield: 123 mg (89%). 1H NMR (CDCl3, 298 K), δ: 8.89 [s, 1H, 3J (Pt–H1) = 45.6, H1]; 7.55 [m, 2H, 339 
H2]; 6.94 [d, 2H, 3J(H3–H2) = 7.6, H3]; 6.70–6.65 [m, 4H, H4–H5]; 6.63 [m, 3H, H6–H8]; 4.46–4.37 340 
[m, 1H, H9]; 4.36–4.23 [m, 2H, H10]; 2.97 [s, 3H, 3J (Pt–H11) = 11.2, H11]; 2.89–2.82 [m, 1H, H9′]; 341 
2.50 [s, 3H, 3J (Pt–H11′) = 16.0, H11′]; 2.34 [s, 3H, H12]; 2.15 [s, 3H, H13]. 19F NMR (CDCl3, 298 342 
K), δ: −112.38 [dd, 3J (F–H) = 10.9, 4J (F–H) = 5.6]. Anal. Found (calcd for C25H28BrFN2Pt): C: 45.9 343 
(46.16); H: 4.7 (4.34); N: 4.4 (4.31). 344 
[PtBr{(4-MeC6H3)(2-FC6H3)CHvNCH2CH2NMe2}] (7-II-Br,F, Chart 3). A solution of [Pt2(4-345 
MeC6H4)4(μ-SEt2)2] (51 mg, 5.45 × 10−5 mol) and 2-Br,6-FC6H3CHvNCH2CH2NMe2 (30 mg, 1.10 346 
× 10−4 mol) in 40 ml of toluene was stirred under reflux for 24 hours. The solvent was removed under 347 
vacuum to yield a yellow powder solid. Yield: 40 mg (65%). 1H NMR (CDCl3, 298 K), δ: 9.06 [s, 1H, 348 
3J (Pt–H1) = 150.4, H1]; 7.55 [td, 1H, 3J(H2–H3,5) = 8.0, 4J(H2–F) = 6.0, H2]; 7.48 [d, 1H, 3J(H5–H2) 349 
= 8.0, H5]; 7.23 [s, 1H, H3]; 7.02 [ddd, 1H, 3J(H4–F) = 10.0, 3J(H4–H2) = 8.0, 4J(H4–H2) = 1.0, H4]; 350 
6.85 [d, 1H, 3J(H6–H7) = 8.0, H6]; 6.78 [dd, 1H, 3J(H7–H6) = 8.0, 4J(H7–H4) = 1.6, H7]; 4.51 [m, 1H, 351 
2J(H8–H8′) = 11.6, 3J(H8–H10,10′) = 4.4, 4J(H8–H1) = 1.2, H8]; 3.88 [m, 1H, 2J(H8′–H8) = 12.0, 352 
3J(H8′–H10,10′) = 4.0, 3J (Pt–H8′) = 61.2, H8′]; 3.04 [s, 3H, H9]; 2.76 [s, 3H, H9′]; 2.70–2.56 [m, 2H, 353 
H10,10′]; 2.30 [s, 3H, H11]. 19F NMR (CDCl3, 298 K), δ: −118.62 [ddd, 3J (F–H) = 11.2, 4J (F–H) = 354 
6.4, 5J (F–H) = 2.4]. Anal. Found (calcd for C18H20BrFN2Pt·H2O): C: 37.3 (37.51); H: 3.8 (3.85); N: 355 
4.8 (4.86). 356 
[Pt(4-MeC6H4)2{(2-F,6-ClC6H3)CHvNCH2CH2NMe2}], (Chart 4). A solution of [Pt2(4-357 
MeC6H4)4(μ-SEt2)2] (199 mg, 2.13 × 10−4 mol) and 2-Cl,6-FC6H3CHvNCH2CH2NMe2 (98 mg, 358 
4.28 × 10−4 mol) in 40 ml of toluene was stirred at room temperature for 4 hours. The solvent was 359 
removed under vacuum to yield yellow oil. The oil was treated with diethyl ether and upon removal of 360 
ether under vacuum a yellow powder was obtained. The yellow solid was recrystallised in 361 
dichloromethane–methanol to yield yellow crystals. Yield: 234 mg (91%). 1H NMR (CDCl3, 298 K), E-362 
isomer, δ: 8.71 [s, 1H, 3J (Pt–H1) = 50.8, H1]; 7.24 [d, 2H, 3J(H2–H6) = 8.0, H2]; 6.97 [dt, 1H, 3J(H3–363 
H4,7) = 8.0, 4J (F–H3) = 6.0, H3]; 6.80 [d, 1H, 3J(H4–H3) = 8.0, H4]; 6.73 [d, 2H, 3J(H5–H8) = 8.0, 364 
H5]; 6.69 [d, 2H, 3J(H6–H2) = 8.0, H6]; 6.54 [t, 1H, 3J(H7–H3) = 3J(H7–F) = 8.8, H7]; 6.17 [d, 2H, 365 
3J(H8–H5) = 8.0, H8]; 4.15 [m, 2H, H9]; 2.78 [t, 2H, 3J(H10–H9) = 5.6, H10]; 2.63 [s, 6H, H11]; 2.13 366 
[s, 3H, H12]; 1.90 [s, 3H, H13]. Z-isomer, 8.41 [s, 1H, 3J (Pt–H1) = 32.0, H1]; 2.64 [s, 6H, H11]; 2.18 367 
[s, 3H, H12]. 19F NMR (CDCl3, 298 K), δ: −108.08 [dd, 3J (F–H) = 9.2, 4J (F–H) = 6.0]. Anal. Found 368 
(calcd for C25H28ClFN2Pt): C: 49.3 (49.55); H: 5.0 (4.66); N: 4.6 (4.62).  369 
[PtCl(4-MeC6H4)2{3-FC6H3CHvNCH2CH2NMe2}] (5-IV-Cl,F, Chart 5). A solution of [Pt2(4-370 
MeC6H4)4(μ-SEt2)2] (200 mg, 2.14 × 10−4 mol) and 2-Cl,6-FC6H3CHvNCH2CH2NMe2 (99 mg, 371 
4.32 × 10−4 mol) in 40 ml of toluene was stirred at room temperature for 48 hours. The solvent was 372 
removed under vacuum to yield yellow oil. The oil was treated with diethyl ether and upon removal of 373 
ether under vacuum a yellow green powder was obtained. Yield: 208 mg (80%). 1H NMR (CDCl3, 298 374 
K), δ: 8.90 [d, 1H, 4J(H1–H10) = 1.6, 3J (Pt–H1) = 46.0, H1]; 7.48 [d, 2H, 3J(H2–H6) = 8.0, H2]; 7.31 375 
[m, 1H, H3]; 7.24 [dd, 1H, 3J(H4–H5) = 8.0, 4J(H4–H3) = 1.6, H4]; 7.09 [t, 1H, 3J(H5–H3,4) = 7.6, 376 
H5]; 6.95 [d, 2H, 3J(H6–H2) = 8.4, H6]; 6.73 [d, 2H, 3J(H7–H8) = 8.4, H7]; 6.64 [d, 2H, 3J(H8–H7) = 377 
8.4, H8]; 4.45–4.35 [m, 1H, H9]; 4.34–4.20 [m, 2H, H10]; 2.85 [s, 3H, 3J (Pt–H11) = 11.2, H11]; 2.81–378 
2.73 [m, 1H, H9′]; 2.51 [s, 3H 3J (Pt–H11′) = 16.0, H11′]; 2.34 [s, 3H, H12]; 2.15 [s, 3H, H13]. 19F 379 
NMR (CDCl3, 298 K), δ: −112.42 [dd, 3J (F–H) = 10.4, 4J (F–H) = 5.6]. Anal. Found (calcd for 380 
C25H28ClFN2Pt): C: 49.4 (49.55); H: 5.1 (4.66); N: 4.7 (4.62). 381 
E-[PtBr(4-MeC6H4){(4-MeC6H4)(2-FC6H3)CHNCH2CH2NMe2}] (II-Br,F, Chart 6). Compound 382 
[PtBr(4-MeC6H4)2{3F-C6H3CHv NCH2CH2N(Me)2}] (5-IV-Br,F) (50 mg, 7.69 × 10−5 mol) was 383 
dissolved in 10 ml of toluene and stirred at 70 °C for 90 minutes. The solvent was removed to yield 384 
quantitatively a yellow solid (50 mg). The 1H NMR spectrum recorded in CDCl3 indicated 90% 385 
conversion of 5-IV-Br,F into II-Br,F. Recrystallization of the crude solid affords XRD quality crystals; a 386 
reproducible yield could not be obtained under these conditions. 1H NMR (CDCl3, 298 K), δ: 8.76 [s, 387 
1H, 3J (Pt–H1) = 35.6, H1]; 7.49 [d, 2H, 3J(H2–H4) = 8.0, H2]; 7.44 [td, 1H, 3J(H3–H5,7) = 8.0, 4J (F–388 
H3) = 5.6, H3]; 7.30 [d, 2H, 3J(H4–H2) = 8.0, H4]; 7.14 [dd, 1H, 3J(H5–H3) = 8.0, 5J(H5–H6) = 0.8, 389 
H5]; 7.10 [d, 2H, 3J(H6–H8) = 8.0, H6]; 7.09 [m, 1H, H7]; 6.77 [d, 2H, 3J(H8–H6) = 8.0, H8]; 3.84 [t, 390 
2H, 3J(H9–H11) = 5.6, H9]; 2.73 [s, 3H, H10]; 2.61–2.54 [m, 2H, H11]; 2.47 [s, 3H, H10′]; 2.41 [s, 3H, 391 
H12]; 2.23 [s, 3H, H13]. 392 
E/Z-[PtBr(4-MeC6H4){(4-MeC6H4)(2-FC6H3)CHNCH2CH2NMe2}] (II′-Br,F). A solution of 10 393 
mg of II-Br,F in toluene was heated at 90 °C for 24 hours. The solvent was removed and the 1H NMR 394 
spectrum was recorded in CDCl3, indicating a nearly quantitative conversion of II-Br,F into II′-Br,F. 395 
Recrystallization of the crude solid (9 mg) affords XRD quality crystals of the Z-isomer; a reproducible 396 
yield could not be obtained under these conditions. 1H NMR (CDCl3, 298 K), E-isomer, δ: 8.84 [s, 1H, 397 
3J (Pt–H) = 152.0, H1]; 6.97 [d, 2H, 3J(H–H) = 8.0]; 6.62 [d, 1H, 3J(H–H) = 8.0]; 6.25 [d, 1H, 3J(H–H) 398 
= 8.0]; 4.23 [m, 2H]; 2.74 [s, 6H]; 2.41 [s, 3H]; 2.11 [s, 3H]. Z-isomer, δ: 8.22 [s, 1H, 3J (Pt–H1) = 399 
84.0, H]; 7.43 [m, 1H]; 6.81 [d, 1H, 3J(H–H) = 8.0]; 6.58 [d, 1H, 3J(H–H) = 8.0]; 6.42 [d, 1H, 3J(H–H) 400 
= 8.0]; 3.42 [m, 2H]; 2.72 [s, 6H]; 2.44 [s, 3H]; 2.12 [s, 3H].  401 
 402 
 403 
X-ray structure analysis 404 
Prismatic crystals were selected and intensity data were measured on a D8 Venture system equipped 405 
with a multilayer monochromator and a Mo microfocus. The structure was solved using the Bruker 406 
SHELXTL software package, and refined using SHELXL.24 All hydrogen atom positional parameters 407 
were computed and refined using a riding model, with an isotropic temperature factor equal to 1.2 times 408 




The kinetic profiles for the reactions were followed by UV-Vis spectroscopy in the full 700–300 nm 413 
range on HP8452A or Cary50 instruments equipped with thermostated multicell transports. The 414 
observed rate constants were derived from absorbance versus time traces at the wavelengths where a 415 
maximum increase and/or decrease of absorbance were/was observed; alternatively the full spectral 416 
time—resolved changes where used. For the reactions carried out at varying pressures, the previously 417 
described pillbox cell and pressurising system25–28 were used and the final treatment of data was the 418 
same as described before. The calculation of the observed rate constants from the absorbance versus 419 
time monitoring of reactions, studied under first order concentration conditions, was carried out using 420 
the SPECFIT or RecatLab software.29,30 The general kinetic technique is that previously 421 
described.11,18,31 Table S1† collects the kobs values for all the systems studied as a function of 422 
starting complex, pressures and temperatures studied. All post-run fittings were carried out by using the 423 
standard available commercial programs. 424 
 425 
Computational details 426 
All the structures have been optimized without restrictions in xylene using the B3LYP density 427 
functional32–34 including the D3 version of Grimme’s dispersion35 as implemented in the Gaussian09 428 
package.36 The standard 6-31G* basis set37–39 was used for all H, C, N, F, Cl and Br atoms; the Los 429 
Alamos National Laboratory double zeta basis set (LANL2DZ)39–41 along with the associated ECP 430 
describing the core electrons, was employed for Pt. The (IEF-PCM) method,42,43 including the radii 431 
and non-electrostatic terms for Truhlar and coworkers’ SMD solvation model,44 was employed. In all 432 
cases, frequency calculations were carried out to confirm the nature of stationary points and transition 433 
states, with none and one negative value, respectively. Additional single point calculations on the 434 
optimized geometries were employed to obtain improved solvated free energy values with larger basis 435 
sets at 139 °C, the boiling point of xylene. The aug-cc-pVTZ basis set including polarization and the 436 
associated electron core potential45,46 was employed for Pt and Br whereas all the other atoms were 437 
described with the 6-311+G** all-electron basis set.45,47,48 All the free energy values reported in the 438 
text correspond to those obtained with the larger basis sets and can be found, along their relevant 439 
thermochemical terms, in Table S3.† 440 
The kinetic models have been constructed with the Copasi software49 using the deterministic (LSODA) 441 
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.522 
Legends to figures 523 
 524 
Figure 1 Molecular structures of compounds (a) 7-II-Br,F, (b) II-Br,F (E form), and (c) II’-Br,F (Z 525 
form); hydrogen atoms have been omitted for clarity. 526 
 527 
Figure 2. a) Eyring plot (60–90 °C) for the dependence of the rate constants of the steps monitored by 528 
UV-Vis spectroscopy on the 5-IV-Br,F → 7-II-Br,F reaction. (b) Pressure dependence ln k versus P for 529 
the same processes. 530 
 531 
Figure 3 Qualitative product concentration evolution over time for II’-X,H (X = Br, Cl) on the arbitrary 532 
time scale. 533 
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Table 1. Selected bond lengths (Å) and angles (°) for the structures determined for compounds 7-II-624 






  631 
Table 2 Kinetic and thermal activation parameters for the two reaction steps observed for the reaction of 632 
different 5-IV-X,Y leading to 7-II-X,Y according to Scheme 5 in xylene solution. * indicates a mixture 633 
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Table 3 Computed relative free energies (kJ mol−1 at 139 °C) for the E and Z forms of the II-X,H and 641 
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Table 4 Crystallographic and refinement data for compounds 7-II-Br,F, II-Br,F (E form), and II’-Br,F 647 
(Z form) 648 
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